The market for anti-obesity drugs has been growing for a while, but is finally about to take off with the entry of two global ...

Researchers warned that to achieve such reductions, greater uptake of the medication among indicated patients is needed.

Semaglutide associated with increased walking distance in patients with symptomatic peripheral artery disease and type 2 diabetes.

The 40-week SUSTAIN 7 trial investigated the efficacy and safety of 0.5 mg semaglutide compared with 0.75 dulaglutide and 1.0 mg semaglutide compared with 1.5 mg dulaglutide, when added to metformin.

semaglutide, which is a glucagon-like peptide-1 (GLP-1) receptor agonist. A key difference between compounded semaglutide and Ozempic is the lack of FDA approval for compounded semaglutide.

Novo Nordisk's GLP-1 receptor agonist semaglutide has been shown to help people struggling with alcohol use disorder (AUD) reduce the amount they drink – pointing to yet another potential use ...

Rybelsus (semaglutide) and Ozempic (semaglutide ... Strengths are listed in milligrams (mg) and mg per milliliter (mg/mL). Rybelsus for type 2 diabetes Ozempic for type 2 diabetes You’ll ...

Listening to the news can feel like a journey. But 1A guides you beyond the headlines – and cuts through the noise. Let's get to the heart of the story, together – on 1A.